(Q33856724)

English

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

David R. H. Christie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Allison Steigler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

David S Lamb

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

David Joseph

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sandra Turner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

John Matthews

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Chris Atkinson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

John North

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nigel A Spry

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Keen-Hun Tai

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Chris Wynne

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Catherine D'Este

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

451-459

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between serum testosterone fall and cognitive function in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy after prostatectomy: is the evidence for dose escalation out there?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970063-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70063-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440505%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33856724&oldid=1970630709"